+91-8668442535

Small Animal Respiratory Diseases Treatment Market By Type Of Diseases (Allergic Pneumonitis, Canine Influenza, Canine Nasal Mites, Lung Nematodes, Neoplasia Of Respiratory System, Pneumonia, Rhinitis And Sinusitis, Tonsilitis), By Type Of Drug Class (Anthelmintics, Non-steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Antibiotics, Antihistamines, Phosphodiesterase (PDE) inhibitors, Bronchodilators, Antineoplastic Agents) - Growth, Future Prospects & Competitive Analysis, 2016 - 2024

This report on global small animal respiratory diseases treatment market studies various type of diseases, drug class and geography. According to veterinary medical experts, upper respiratory infections– also called canine infectious respiratory disease (CIRD) is mainly caused in spaces occupied or visited by many pets such as boarding houses, groomers, and parks. These kind of infections are also known commonly as "Kennel Cough" because of the honking, dry sound made by infected animals, URI in pets is complex to diagnose because it can be caused by both bacteria or viruses and in most cases multiple agents are involved. These infections are highly contagious especially when dogs or cats get together in high-density situations such as pet stores and animal shelters the sanitization is the most important factor. 

For the purpose of this study, the various types of diseases considered are allergic pneumonitis, canine influenza, canine nasal mites, lung nematodes, neoplasia of respiratory system, pneumonia, rhinitis and sinusitis, tonsilitis, and others. Market size estimates and forecast for these segments for the period 2014 to 2024 are provided in terms of USD Mn along with the respective CAGRs for the period 2016 to 2024, considering 2015 as the base year.

The market segmentation on the basis types of drug class comprises sub-segments such as anthelmintics, NSAIDs, corticosteroids, antibiotics, antihistamines, phosphodiesterase (PDE) inhibitors, bronchodilators, antineoplastic agents, and others. Market size estimates and forecast for these segments for the period 2014 to 2024 are provided in terms of USD Mn along with the respective CAGRs for the period 2016 to 2024, considering 2015 as the base year.

The geographic segmentation of the global small animal respiratory diseases treatment market is performed for the regions North America, Europe, Asia-Pacific, Latin America and Middle East & Africa markets. The regions are also further sub-segmented on the basis of major countries. Market size estimates and forecast for these segments for the period 2014 to 2024 are provided in terms of USD Mn along with the respective CAGRs for the period 2016 to 2024, considering 2015 as the base year.

The key players covered in small animal respiratory diseases treatment market are Zoetis, Inc., Merck Animal Health, Merial Inc. (Sanofi S.A), Boehringer Ingelheim GmbH, Elanco Animal Health (Eli Lilly), Bayer AG, Ceva Animal Health, Heska Corporation, Vetoquinol SA, Virbac Ltd., and Cipla Vet.

For the purpose of this study, the global small animal respiratory diseases treatment market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Small Animal Respiratory Diseases Treatment Market

North America was observed as the largest market for small animal respiratory diseases treatment market due to factors such as rising air pollution, lack of sanitation related to pets in a few households, increasing urban trend of having dogs and cats as pets and rising awareness associated with the well-being of small animals. The European small animal respiratory diseases treatment market has displayed significant growth recently, albeit from a fairly low base compared to other regions. According to market experts, consumers in the region are more likely to own pets and provide them all the facilities as a family member. There is a noticeable inclination towards pet humanization, especially among young, urban and affluent consumers, and is expected to trade up to mid-priced or premium products. In 2015, Asia-Pacific was observed as the fastest growing small animal respiratory diseases treatment market due to key driving factors such as rising trend of keeping dogs and cats as pet in urban areas, increasing awareness in pet owners especially associated with several life-threatening diseases, and pet humanization trend is increasing rapidly in Asian countries.

Choose License Type
Budget Buying
Executive Summary - Brief Global Market Size - Current & Forecast
Regional Market Size - North America
Country Market Size - US
Company Profile – 1
Trusted By
Godaddy
Published Date:  Jan 2017
Category:  Pharmaceuticals
Report ID:   58332
Report Format:   PDF
Pages:   120
Rating:    4.5 (60)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support